slides · global inventory
Introduce Nominees
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,244
Current window 451-480
Pages 75
Rows per page 30
Slide function
451-480 of 2,244
258
The slide uses a Q&A format to highlight negative sentiment from a key opinion leader (KOL).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
260
The slide uses a Q&A format to validate the negative sentiment expressed in the summary header.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
264
Includes direct quotes from the physician regarding his clinical experience and frustrations with insurance paperwork.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
270
Includes verbatim Q&A excerpts highlighting patient volume and discontinuation rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
272
The slide uses a Q&A format to expose negative feedback regarding drug interactions and side effects.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
274
The slide presents qualitative expert testimony regarding drug discontinuation rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
277
The slide uses a Q&A format to validate the prescriber's credentials and patient volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
278
The slide uses a Q&A format to present qualitative feedback from a specific physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
284
The slide uses a Q&A format to document a specific adverse event case study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
287
The slide uses a Q&A format to provide evidence for the summary points listed in the title.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
170
The slide uses red borders to emphasize the co-founders, contrasting them with the CEO and CFO.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
169
The slide provides context for an upcoming expert testimony, highlighting the relationship between Lasertec, Cymer (ASML), and Isteq.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
58
This slide functions as a 'villain_critique' or 'expose_contradiction' regarding the drug's clinical reception.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
61
This slide presents expert testimony/critique from a trial investigator, serving as a 'villain_critique' or 'expose_contradiction' style slide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
62
The slide uses a 'nominee_bio' structure to present a 'villain_critique' or 'expose_contradiction' narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
63
The slide uses direct quotes to expose potential data omissions and competitive disadvantage.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
64
The slide uses direct quotes from an expert to undermine the commercial viability and clinical efficacy of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
66
This slide is part of a series of 'investigator' profiles used to build a case against a company's clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
67
The slide presents critical expert feedback on drug formulation and safety protocols.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
75
The slide uses direct quotes from an expert consultation to undermine the company's product launch and clinical efficacy claims.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
77
The slide serves as a negative testimonial/expert critique of the product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
81
The slide captures qualitative feedback from a medical expert, highlighting low adoption rates and negative sentiment toward the company's sales approach.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
85
The slide uses direct quotes to highlight the physician's lack of confidence in the drug and his perception of external pressure from patient advocacy groups.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
89
This slide presents qualitative interview data from a medical expert to undermine the credibility of a drug and a key opinion leader.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
90
The slide uses direct quotes to frame the expert's skepticism regarding the company's marketing and clinical rationale.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
92
The slide presents qualitative expert feedback from a medical professional regarding drug safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
93
The slide presents qualitative feedback from a medical expert, highlighting concerns about diabetes risk and comparing the drug to the Aduhelm controversy.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
96
The slide presents a qualitative critique from a medical professional, highlighting skepticism regarding clinical efficacy and administrative burden.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
99
The slide uses direct quotes to highlight the expert's negative sentiment and concerns regarding side effects and reimbursement.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
101
The slide uses direct quotes to expose contradictions in the drug's adoption and safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit